Related Experiment Videos
Promoting couples collaboration in type 2 diabetes: the diabetes support project pilot data
Paula Trief1, Jonathan G Sandberg, Robert Ploutz-Snyder
1Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY 13210, USA. triefp@upstate.edu
Summary
This pilot study shows telephone-delivered interventions can improve Type 2 diabetes management for patients and partners. Both individual and couples approaches improved medical outcomes and blood glucose control.
Area of Science:
- Endocrinology
- Behavioral Medicine
- Public Health
Background:
- Type 2 diabetes self-management is complex and often benefits from social support.
- Couples-based interventions may enhance patient engagement and adherence to treatment plans.
- Telephone delivery offers a feasible method for reaching diverse patient populations.
Purpose of the Study:
- To assess the feasibility and potential efficacy of a couples-focused, telephone-delivered intervention for Type 2 diabetes self-care.
- To compare a couples intervention with an individual intervention and standard diabetes education.
- To evaluate the impact on blood glucose control and other medical outcomes.
Main Methods:
- A pilot randomized controlled trial involving 44 couples where one partner had Type 2 diabetes.
- Participants were assigned to a couples intervention, individual intervention, or individual diabetes education.
- Interventions focused on collaborative problem-solving, goal-setting, dietary changes, and emotional support, delivered via telephone.
Main Results:
- Both individual and couples interventions demonstrated meaningful clinical improvements in medical outcomes.
- Standard diabetes education also led to improved blood glucose control.
- Statistically significant treatment effects were observed for total cholesterol, despite the small sample size.
Conclusions:
- Telephone-delivered interventions are feasible and potentially efficacious for Type 2 diabetes management in patients and their partners.
- The findings support the refinement and further evaluation of this intervention in larger trials.
- Collaborative approaches within couples show promise for improving diabetes self-care and health outcomes.
Related Concept Videos
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...